U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Afluria Quadrivalent, Afluria Quadrivalent Southern Hemisphere
  1. Vaccines

Afluria Quadrivalent, Afluria Quadrivalent Southern Hemisphere

STN: BL 125254
Proper Name: Influenza Vaccine
Tradename: Afluria Quadrivalent, Afluria Quadrivalent Southern Hemisphere
Manufacturer: Seqirus Pty Ltd.
Indication:

  • Afluria: Active immunization against influenza disease cause by influenza virus subtypes A and type B present in the vaccine. Afluria is approved for use in persons 6 months of age and older.
  • Afluria Quadrivalent: Active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Afluria Quadrivalent is approved for use in persons 6 months of age and older.

Product Information

Supporting Documents

Back to Top